Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 18Terminated 9Recruiting 9Unknown 7Not yet recruiting 5Active not recruiting 4Withdrawn 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1

Conditions

Endometrial Neoplasms 1Endometrial Hyperplasia 1Anorexia 1

Interventions

Cyclophosphamide 128Cisplatin 119Radiotherapy 111pembrolizumab 110Paclitaxel 96Gemcitabine 96Carboplatin 96Nivolumab 76Magnetic Resonance Spectroscopy 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Doxorubicin 52fludarabine 51Biopsy 48durvalumab 44Cytarabine 44Drug Therapy 43Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Lenalidomide 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Interventional × Megestrol Acetate × Clear all
NCT01943058 2014-09-10

Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer

University of Southern California

Phase 2 Withdrawn
Gynecologic

Endometrial Hyperplasia, Endometrial Neoplasms

NCT01501396 2014-02-03

Megestrol Acetate With or Without Mirtazapine in Treating Cancer Patients With Weight Loss or Loss of Appetite

Washington University School of Medicine

Phase 2 Withdrawn

Anorexia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡